PharmTech Europe News

Circio and Certest to Collaborate on LNP Formulations

November 21, 2024

The companies will collaborate to create and test circVec DNA–LNP formulations for use in potential therapeutic applications.

Three New European Facilities Established by BioPharmaSpec for R&D

November 21, 2024

Located in German, Italy, and Lithuania, the new European facilities will specialize in drug discovery and R&D services.

CDMO SEKISUI Expands its CGMP Biopharma Manufacturing Capacity

November 20, 2024

SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

November 19, 2024

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

EMA’s CHMP Gives Positive Opinion for Use of Lecanemab in Early Alzheimer’s Disease

November 16, 2024

CHMP has granted Eisai Europe and Biogen a positive opinion for the use of their monoclonal antibody therapy in treating early Alzheimer’s disease.

J&J’s Balversa Gains MHRA Marketing Authorization as Monotherapy for Bladder Cancer

November 08, 2024

Balversa (erdafitinib) marks the first and only bladder cancer therapy to target FGFR3 alterations, with a demonstrated increase in overall survival from 7.8 months to 12.1 months.

UK Medicines Manufacturing Skills Centre Stresses Skill Development after Budget Announcement

November 08, 2024

A £520 million investment for manufacturing capacity was announced by Chancellor of the Exchequer, Rachel Reeves, but academic and industry leaders stress the money should be used to train personnel.

Denmark’s First AI Supercomputer for Drug Discovery Now Operational Under Novo Nordisk Foundation Commitment

November 01, 2024

With DKK 600 million (US$87.4 million) in funding from the Novo Nordisk Foundation, the new supercomputer offers the potential to accelerate innovation in drug discovery.

Regulatory Collaboration on Mpox Treatments Summarized in Report

October 25, 2024

The report highlights international regulators’ plans for the development and availability of vaccines to prevent and drugs to treat mpox.

Several Medicines Recommended by EMA’s CHMP in October

October 18, 2024

The agency’s CHMP recommended drugs to treatments for hemophilia, two biosimilars for psoriasis, and two flu vaccines at their October meeting.